What this study is
The overall goal of Transforming Research and Clinical Knowledge in Spinal Cord Injury (TRACK-SCI) study is to determine the relationships among the clinical, neuroimaging, cognitive, genetic and proteomic biomarker characteristics of acute traumatic spinal cord injury (SCI). TRACK-SCI seeks to combine high quality care variables with high density physiology data collection to better understand diagnose, characterize, and track the temporal profile of recovery for SCI patients. The Investigators are enrolling patients within 24 hours of injury who present to a TRACK-SCI site with a spinal cord injury that meets eligibility criteria.
Study details
- Official title
- Early Critical Care Decisions and Outcomes After SCI: TRACK-SCI
- Sponsor
- University of California, San Francisco
- Conditions
- Spinal Cord Injuries
- Enrolling
- 726 people
- Starts
- 2015-05-14
- Est. completion
- 2028-12-01
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers AcceptedYou may qualify if
- For SCI group: individuals at least 18 years of age recently diagnosed with acute, traumatic spinal cord injury
- For Trauma Control group: individuals at least 18 years of age recently diagnosed with acute, traumatic injury that is not spinal cord injury
- For Healthy Control group: generally healthy individuals at least 18 years of age not recently diagnosed with acute, traumatic injury (including SCI)
You can't join if
- Individuals who are pregnant
- Individuals who are in-custody/prisoners
- Individuals who are under psychiatric hold
- For non-SCI individuals, they must not have had a spinal cord injury in the past
- For non-SCI individuals, they must not have a history of previous central nervous system injury (i.e. stroke, spinal cord injury, traumatic brain injury, seizures, etc.)
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (5)
5 openUniversity of California, San Francisco - Fresno
Fresno, California, United States
University of California, San Francisco
San Francisco, California, United States
Ohio State University
Columbus, Ohio, United States
University of Utah
Salt Lake City, Utah, United States
University of Washington
Seattle, Washington, United States
Study team
Sponsor
University of California, San Francisco
Study ID SC150198
Principal investigator
Michael S Beattie, PhD
University of California, San Francisco
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.